Genesis Healthcare, Inc. provided earnings guidance for the fourth quarter and year ended December 31, 2015. For the quarter, the company expects adjusted net revenues range from $1,410.0 million to $1,440.0 million. Adjusted EBITDAR of range from $158.0 million to $164.0 million. Adjusted EBITDA of range from $36.0 million to $42.0 million. Adjusted diluted loss per share of range from $0.06 to $0.04 per share.

For the year, the company expects adjusted net revenues range from $5,628.0 million to $5,658.0 million. Adjusted EBITDAR of range from $730.0 million to $736.0 million. Adjusted EBITDA of range from $246.0 million to $252.0 million. Adjusted diluted earnings per share of range from $0.21 to $0.23 per share.

For the year 2016, the company expects adjusted net revenues of range from $5,700.0 million to $5,800.0 million. Adjusted EBITDAR of range from $765.0 million to $795.0 million. Adjusted EBITDA of range from $267.0 million to $297.0 million. Adjusted diluted earnings per share of range from $0.19 to $0.29 per share.